Brian A Leuthner Insider Trading $EDGE PDS Biotechnology Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Brian A Leuthner.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Brian A Leuthner. Brian A Leuthner is Chief Operating Officer in ONCOSEC MEDICAL Inc ($ONCS) and Chief Executive Officer in Edge Therapeutics, Inc. ($EDGE) and President and CEO in Edge Therapeutics, Inc. ($EDGE).

Brian A Leuthner in PDS Biotechnology Corp

Trading Symbol: EDGE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian A Leuthner: President and CEO, Chief Executive Officer
Holdings: 239,268 shares
Current Value: $2,285,009
Latest Transaction: Mar 18 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Brian A Leuthner in PDS Biotechnology Corp

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ONCS, EDGE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 18 2019EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOOption ExerciseM0.00169,03200
Mar 18 2019EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOBuyM0.00169,0320239,26870.2 K to 239.3 K (+240.66 %)
Aug 15 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOOption ExerciseA0.00169,0320169,032
Jun 20 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOOption ExerciseA1.10338,068371,875338,068
Mar 05 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOOption ExerciseA14.98280,0004,194,400280,000
Mar 05 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS15.082,50037,70070,23672.7 K to 70.2 K (-3.44 %)
Mar 05 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS14.812,50037,02572,73675.2 K to 72.7 K (-3.32 %)
Feb 23 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS15.372,50038,42575,23677.7 K to 75.2 K (-3.22 %)
Feb 23 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS15.472,50038,67577,73680.2 K to 77.7 K (-3.12 %)
Feb 02 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS12.962,50032,40080,23682.7 K to 80.2 K (-3.02 %)
Feb 02 2018EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS13.142,50032,85082,73685.2 K to 82.7 K (-2.93 %)
Dec 05 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.682,50024,20090,23692.7 K to 90.2 K (-2.70 %)
Dec 05 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.972,50024,92592,73695.2 K to 92.7 K (-2.63 %)
Dec 05 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.922,50024,80095,23697.7 K to 95.2 K (-2.56 %)
Nov 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.862,50027,15097,736100.2 K to 97.7 K (-2.49 %)
Nov 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.942,50027,350100,236102.7 K to 100.2 K (-2.43 %)
Nov 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.922,50027,300102,736105.2 K to 102.7 K (-2.38 %)
Oct 04 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS11.142,50027,850105,236107.7 K to 105.2 K (-2.32 %)
Oct 04 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.932,50027,325107,736110.2 K to 107.7 K (-2.27 %)
Oct 04 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.812,50027,025110,236112.7 K to 110.2 K (-2.22 %)
Sep 06 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.312,50025,775112,736115.2 K to 112.7 K (-2.17 %)
Sep 06 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.942,50024,850115,236117.7 K to 115.2 K (-2.12 %)
Sep 06 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.372,50025,925117,736120.2 K to 117.7 K (-2.08 %)
Aug 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.402,50026,000120,236122.7 K to 120.2 K (-2.04 %)
Aug 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.532,50026,325122,736125.2 K to 122.7 K (-2.00 %)
Aug 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.652,50026,625125,236127.7 K to 125.2 K (-1.96 %)
Jul 06 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.082,50025,200127,736130.2 K to 127.7 K (-1.92 %)
Jul 06 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.212,50025,525130,236132.7 K to 130.2 K (-1.88 %)
Jul 06 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.272,50025,675132,736135.2 K to 132.7 K (-1.85 %)
May 09 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS11.101001,110135,236135.3 K to 135.2 K (-0.07 %)
Mar 15 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOOption ExerciseA8.86267,5002,370,050267,500
Feb 08 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.521,50014,280245,479247 K to 245.5 K (-0.61 %)
Feb 07 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.521,50014,280246,979248.5 K to 247 K (-0.60 %)
Feb 07 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.691,50014,535248,479250 K to 248.5 K (-0.60 %)
Feb 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.611,50014,415249,979251.5 K to 250 K (-0.60 %)
Feb 03 2017EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.381,50014,070251,479253 K to 251.5 K (-0.59 %)
Dec 02 2016EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS11.607,50087,000252,979260.5 K to 253 K (-2.88 %)
Oct 04 2016EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS10.257,50076,844260,479268 K to 260.5 K (-2.80 %)
Aug 02 2016EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.547,50071,582267,979275.5 K to 268 K (-2.72 %)
Aug 02 2016EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOSellS9.547,50071,582267,979275.5 K to 268 K (-2.72 %)
Feb 18 2016EDGEEdge Therapeutics, ...Leuthner Brian APresident and CEOOption ExerciseA6.99230,0001,607,700230,000
Oct 08 2015EDGEEdge Therapeutics, ...Leuthner Brian AChief Executive Off ...Option ExerciseC0.003,65500
Oct 08 2015EDGEEdge Therapeutics, ...Leuthner Brian AChief Executive Off ...BuyJ8.6080688550,958550.9 K to 551 K (+0.01 %)
Oct 08 2015EDGEEdge Therapeutics, ...Leuthner Brian AChief Executive Off ...BuyC0.002,6720550,878548.2 K to 550.9 K (+0.49 %)

Page:   1

Contact us | Follow us on Twitter